Inari Medical, Inc.

Inari Medical, Inc.

NARI
Inari Medical, Inc.US flagNASDAQ Global Select
79.97
USD
- -
- -
4.68BMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Sales/Revenue/Turnover
7
51
140
277
383
494
+ Sales & Services Revenue
7
51
140
277
383
494
- Cost of Revenue
1
6
13
25
45
59
+ Cost of Goods & Services
1
6
13
25
45
59
Gross Profit
6
45
127
252
339
435
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- Operating Expenses
15
44
108
241
367
449
+ Selling, General & Admin
11
37
90
190
293
361
+ Research & Development
4
7
18
51
74
88
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-9
1
18
11
-28
-14
- Non-Operating (Income) Loss
1
2
5
- -
-2
-18
+ Interest Expense, Net
1
1
1
- -
-2
-15
+ Interest Expense
1
1
1
- -
- -
- -
- Interest Income
- -
- -
- -
- -
2
16
+ Other Non-Op (Income) Loss
- -
1
4
- -
- -
-3
Pretax Income
-10
-1
14
11
-26
4
- Income Tax Expense (Benefit)
- -
- -
- -
1
3
6
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-10
-1
14
10
-29
-2
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-10
-1
14
10
-29
-2
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-10
-1
14
10
-29
-2
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-10
-1
14
10
-29
-2
EBIT
-9
1
18
11
-28
-14
EBITDA
-9
1
20
15
-21
-3
EBITDA Margin (%)
-129.7
2.77
14.18
5.47
-5.47
-0.67
EBITA
-9
1
18
11
-28
-14
Gross Margin (%)
81.24
88.44
90.62
91.06
88.39
88.03
Operating Margin (%)
-133.84
1.57
13.19
3.92
-7.33
-2.84
Profit Margin (%)
-148.67
-2.33
9.87
3.55
-7.63
-0.33
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
1
1
4
7
11
Basic Weighted Avg Shares
38
38
32
50
53
57
Basic EPS, GAAP
-0.26
-0.03
0.43
0.2
-0.55
-0.03
Basic EPS from Cont Ops
-0.26
-0.03
0.43
0.2
-0.55
-0.03
Diluted Weighted Avg Shares
45
45
52
56
53
57
Diluted EPS, GAAP
-0.23
-0.03
0.27
0.18
-0.55
-0.03
Diluted EPS from Cont Ops
-0.23
-0.03
0.27
0.18
-0.55
-0.03

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Total Current Assets
26
39
206
245
423
236
+ Cash, Cash Equivalents & STI
22
24
164
176
326
115
+ Cash & Cash Equivalents
22
24
114
93
60
39
+ ST Investments
- -
- -
50
83
266
77
+ Accounts & Notes Receiv
2
11
28
42
59
70
+ Accounts Receivable, Net
2
11
28
42
59
70
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
+ Inventories
1
4
11
21
33
43
+ Raw Materials
- -
1
3
6
14
14
+ Work In Process
- -
1
1
1
3
5
+ Finished Goods
1
2
7
14
15
23
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
1
3
6
5
7
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
5
8
66
81
439
+ Property, Plant & Equip, Net
1
3
7
61
72
69
+ Property, Plant & Equip
2
5
10
66
81
83
- Accumulated Depreciation
1
1
2
5
9
14
+ LT Investments & Receivables
- -
- -
- -
4
- -
- -
+ LT Investments
- -
- -
- -
4
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
2
1
1
9
369
+ Total Intangible Assets
- -
- -
- -
- -
- -
365
+ Goodwill
- -
- -
- -
- -
- -
214
+ Other Intangible Assets
- -
- -
- -
- -
- -
151
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
2
1
1
9
4
Total Assets
27
45
214
312
504
674
+ Payables & Accruals
2
9
14
42
55
75
+ Accounts Payable
1
3
3
7
8
11
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
6
11
35
47
64
+ ST Debt
- -
- -
- -
1
1
2
+ ST Borrowings
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
1
1
2
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
Total Current Liabilities
2
9
14
43
56
76
+ LT Debt
10
19
- -
28
31
30
+ LT Borrowings
10
19
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
28
31
30
+ Other LT Liabilities
54
55
- -
1
- -
103
+ Accrued Liabilities
- -
- -
- -
- -
- -
36
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
54
55
- -
1
- -
66
Total Noncurrent Liabilities
64
75
- -
30
31
133
Total Liabilities
66
84
14
72
87
209
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
2
228
257
463
505
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
2
228
257
463
504
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-40
-41
-27
-18
-47
-48
+ Other Equity
- -
- -
- -
- -
1
9
Equity Before Minority Interest
-39
-39
200
239
417
465
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
-39
-39
200
239
417
465
Total Liabilities & Equity
27
45
214
312
504
674
Shares Outstanding
46
46
49
50
54
58
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
29
32
32
Net Debt
-12
-4
-114
-93
-60
-39
Net Debt to Equity
30.41
10.62
-57.04
-38.77
-14.44
-8.3
Tangible Common Equity Ratio
-146.63
-87.87
93.54
76.78
82.71
32.26
Current Ratio
12.2
4.44
14.86
5.77
7.53
3.09
Cash Conversion Cycle
- -
136.2
202.26
229.98
221.73
232.84

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
+ Net Income
-10
-1
14
10
-29
-2
+ Depreciation & Amortization
- -
1
1
4
7
11
+ Non-Cash Items
- -
2
8
26
30
24
+ Stock-Based Compensation
- -
1
4
25
29
40
+ Deferred Income Taxes
- -
- -
- -
- -
- -
-1
+ Asset Impairment Charge
- -
- -
- -
- -
- -
1
+ Other Non-Cash Adj
- -
1
4
- -
1
-16
+ Chg in Non-Cash Work Cap
-2
-6
-21
-14
-21
3
+ (Inc) Dec in Accts Receiv
-2
-9
-17
-14
-17
-11
+ (Inc) Dec in Inventories
-1
-3
-7
-10
-12
-7
+ (Inc) Dec in Prepaid Assets
- -
-1
-2
-18
-4
10
+ Inc (Dec) in Accts Payable
1
7
5
30
12
12
+ Inc (Dec) in Other
- -
- -
- -
-1
-1
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-11
-5
2
25
-14
36
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-3
-5
-14
-10
-5
+ Acq of Fixed Prod Assets
-1
-3
-5
-14
-10
-5
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
164
6
183
10
+ Increase in Capital Stock
- -
- -
164
6
183
10
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-50
-37
-185
189
+ Dec in LT Investment
- -
- -
- -
97
313
595
+ Inc in LT Investment
- -
- -
-50
-134
-498
-407
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
-240
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
-240
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-3
-55
-51
-195
-58
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
10
-20
- -
- -
- -
+ Cash From Debt
- -
20
10
- -
- -
- -
+ Repayments of Debt
- -
-10
-30
- -
- -
- -
+ Other Financing Activities
27
- -
- -
-1
-6
-9
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
27
10
144
4
177
1
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
15
2
91
-21
-32
-21
EBITDA
-9
1
20
15
-21
-3
EBITDA Margin (%)
-129.7
2.77
14.18
5.47
-5.47
-0.67
Free Cash Flow
-12
-8
-4
12
-24
31
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
240
Free Cash Flow to Firm
- -
- -
-2
12
- -
31
Free Cash Flow to Equity
- -
2
-24
12
-24
31
Free Cash Flow per Basic Share
-0.3
-0.21
-0.11
0.24
-0.45
0.55
Price/Free Cash Flow
- -
- -
610.45
129.67
-835.21
90.69
Cash Flow to Net Income
1.07
4.14
0.14
2.59
0.48
-21.96
Capital Expenditures
-1
-3
-5
-14
-10
-5